Dulaglutide
Comparative Study of Different Weekly GLP-1 Receptor Agonists Among Diabetic and Non-Diabetic Patients: Clinical Trial
Company n/r · Phase 3 · Completed · Enrollment 159
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| obese , non diabetic ,recieve dulaglutide | Obese Diabetics; Obese Non Diabetic | n/r | 24 | n/r | n/r |
| obese , non diabetic ,receive SEMAGLUTIDE | Obese Diabetics; Obese Non Diabetic | n/r | 24 | n/r | n/r |
| obese , non diabetic ,receive TIRAZEPETIDE | Obese Diabetics; Obese Non Diabetic | n/r | 24 | n/r | n/r |
| obese , diabetic ,recieve dulaglutide | Obese Diabetics; Obese Non Diabetic | n/r | 24 | n/r | n/r |
| obese , diabetic ,receive SEMAGLUTIDE | Obese Diabetics; Obese Non Diabetic | n/r | 24 | n/r | n/r |
| obese , diabetic ,receive TIRAZEPETIDE | Obese Diabetics; Obese Non Diabetic | n/r | 24 | n/r | n/r |